Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Clinical investigators in Japan have long suggested that exposure to methamphetamine might cause a persistent schizophrenia-like psychosis. This possibility is discounted in the Western literature. To investigate the relationship between drug use and later schizophrenia, the authors conducted a large-scale cohort study of drug users initially free of persistent psychosis. METHOD: A population-based cohort study was conducted using data from California inpatient hospital discharge records from 1990 through 2000. Patients with methamphetamine-related conditions (N=42,412) and those with other drug use disorders (cannabis, cocaine, alcohol, and opioids) were propensity score-matched to individuals with primary appendicitis who served as a population proxy comparison group; the methamphetamine cohort was also matched to the other drug cohorts. Cox modeling was used to estimate differences between matched groups in the rates of subsequent admission with schizophrenia diagnoses. RESULTS: The methamphetamine cohort had a significantly higher risk of schizophrenia than the appendicitis group (hazard ratio=9.37) and the cocaine, opioid, and alcohol groups (hazard ratios ranging from 1.46 to 2.81), but not significantly different from that of the cannabis group. The risk of schizophrenia was higher in all drug cohorts than in the appendicitis group. CONCLUSIONS: Study limitations include difficulty in confirming schizophrenia diagnoses independent of drug intoxication and the possibility of undetected schizophrenia predating drug exposure. The study's findings suggest that individuals with methamphetamine-related disorders have a higher risk of schizophrenia than those with other drug use disorders, with the exception of cannabis use disorders. The elevated risk in methamphetamine users may be explained by shared etiological mechanisms involved in the development of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The California Hospital Study reported a large association between hospital admission diagnosis of cannabis use disorder and risk of later hospitalisation for schizophrenia (16) compared to a cohort of subjects who were hospitalised for appendicitis (HR 8.16, 95% CI 5.08, 13.12).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [16]
In the citing paper
“Studies that assessed hospitalisation for schizophrenia are unlikely to be substantially affected by this bias (12,16).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [16]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-13 · Cited by 1,072
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Self-citationvan Os, J., Rutten, B. P., & Poulton, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn117 · Cited by 713
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Austin, P. C. (2007) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.07.021 · Cited by 589
Austin, P. C., & Mamdani, M. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2328 · Cited by 560
Shah, B. R., Laupacis, A., Hux, J. E., & Austin, P. C. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.016 · Cited by 493
van Winkel, R., Stefanis, N. C., & Myin-Germeys, I. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn101 · Cited by 489
Appendectomy: A Contemporary Appraisal
Hale, D. A., Molloy, M., Pearl, R. H., Schutt, D. C., & Jaques, D. P. (1997) · Annals of Surgery · doi:10.1097/00000658-199703000-00003 · Cited by 354
Research works printed but not linked: 5
- Angrist B, 1994, Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse, 387
- Zach A, 1990, New Way to Edit: Discharge Data Review
- California Office of Statewide Health Planning and Development, 1995, Editing Criteria Handbook
- Sauerland S, 2004, Cochrane Database Syst Rev, 4, CD001546
- Konuma K, 1994, Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse, 415
Cited by
Items 101–150 of 150
Uludağ, K., Jadhav, A., & Kara, F. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-4439-2.ch007 · Cited by 2
Disorders due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_26 · Cited by 4
Dong, H., Luo, T., Yang, C., Liu, M., Shen, Y., & Hao, W. (2024) · Schizophrenia · doi:10.1038/s41537-024-00506-9 · Cited by 3
“Moreover, cohort studies indicate that a substantial proportion of MIP diagnoses develop into persistent psychotic conditions in the long run 11,12 .”
BackgroundMethamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California
FRANCES, R. J. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.07.131 · Cited by 2
Gastroenteritis exposure and the risk of schizophrenia onset: A systematic review and meta-analysis
Yi, W., Wei, Q., Pan, R., Song, S., Gao, J., Xu, Z., Duan, J., He, Y., Tang, C. K., Liu, X., et al. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110136 · Cited by 2
Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs
Durand, M., Nagot, N., Michel, L., Le, S. M., Duong, H. T., Vallo, R., Vizeneux, A., Rapoud, D., Giang, H. T., Quillet, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.846844 · Cited by 1
Weisbrod, L. J., Schmidt, A. J., Tanabe, J., Sakai, J. T., Ojemann, S. G., Pawlowski, J. R., Shiffermiller, J. F., & Abosch, A. (2025) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20240142 · Cited by 1
Lin, L. M., Febo, M., Bruijnzeel, A. W., Phan, L. T., Gopinath, A., Seibold, J. M., Miller, E., & Khoshbouei, H. (2025) · Science Signaling · doi:10.1126/scisignal.ady8676 · Cited by 2
Appraising the risks of reefer madness.
Murray, R. M. (2015) · PubMed Central · Cited by 3
Amfetaminutløst psykose eller schizofreni?
Rognli, E. B., Medhus, S., & Bramness, J. G. (2015) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.14.1365 · Cited by 3
“Over ti år var risikoen for utvikling av schizofreni hos amfetamingruppen økt ni ganger (11).”
Intensity of Psychoactive Substance Use Affects the Occurrence of Prodromal Symptoms of Psychosis
Więckiewicz, G., Florczyk, I., Stokłosa, M., Jurga, M., Gorczyca, P. W., & Kotlicka‐Antczak, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030760 · Cited by 1
“Studies also suggest that an increased risk of developing schizophrenia may also apply to methamphetamine abusers [26].”
BackgroundLinking Substance Use and Schizophrenia
Mutlu, E., Özden, H. C., & Ertuğrul, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-32046-0_179-1 · Cited by 1
Stimulanzien vom Amphetamin-Typ
Gouzoulis‐Mayfrank, E., Majić, T., & Schaub, M. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00011-4 · Cited by 2
Stimulant use disorders and psychosis: prevalence, correlates and impacts
Sara, G. E. (2014) · The University of Queensland · doi:10.14264/uql.2015.15 · Cited by 1
“The results reported here are less consistent with a recent large study (Callaghan et al., 2012) which found that people admitted to Californian hospitals for methamphetamine abuse and dependence had the same risk of progression to schizophrenia as people with cannabis-related admissions.”
BackgroundResultA new challenge for expert witnesses relying on subjective information
Fisher, B. A. J. (2017) · Forensic Sciences Research · doi:10.1080/20961790.2017.1342587 · Cited by 1
Haghighatfard, A., Seifollahi, S., Rajabi, P., Rahmani, N., & Ghannadzadeh, R. (2021) · Research Square · doi:10.21203/rs.3.rs-668566/v1 · Cited by 1
Björkholm, C. (2013) · Figshare
Multilevel Approaches to Schizophrenia and Other Psychotic Disorders: The Biobehavioral Interface
Walker, E. F., Ryan, A. T., Goines, K., Novacek, D. M., Goulding, S. M., Brasfield, J. L., MacDonald, A. N., & Trotman, H. D. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy322 · Cited by 1
Amfetamin og psykose - behov for mer behandling og forskning
Rognli, E. B., & Bramness, J. G. (2015) · Rus & samfunn · doi:10.18261/issn1501-5580-2015-05-13
Ahmadkhaniha, H., Alavi, K., Rouhi, E., & Najarzadegan, M. R. (2016) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.29749
“Other studies emphasize the psychotic disorder after methamphetamine use (7-12).”
BackgroundDoucet, J.-S. (2012) · TSpace (University of Toronto)
Quelle est la place de la consommation de substances dans les troubles psychotiques émergents ?
Taleb, M. H., Benamar, S. A., & Keddache, C. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76179-9.00007-3
Haghighatfard, A., Seifollahi, S., Rajabi, P., Rahmani, N., & zadeh, R. G. (2021) · Research Square · doi:10.21203/rs.3.rs-144191/v1
“Also, individuals with methamphetamine dependence have a higher risk of schizophrenia (7).”
BackgroundRisicofactoren van psychotische symptomen en hun causaliteit: een overzicht
MEIRLAEN, J. W. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.119
Ahmadkhaniha, H., Alavi, K., Rouhi, E., & Najarzadegan, M. R. (2018) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.64561
Soraya, S., خانیها, ح. ا., & Aminpour, A. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220929113437
Zhang, S., Luo, J., Zeng, Y., Ren, H., Chen, Z., & Ren, Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-062491
Disorders Due to Substance Use: Stimulants
Sevarino, K. A., & Farrell, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_26-1 · Cited by 1
Stimulanzien vom Amphetamin-Typ
Gouzoulis‐Mayfrank, E., Majić, T., & Schaub, M. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00014-9 · Cited by 3
(2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.fm02
Chapter 6. Depressive Disorders and Substance Use Disorders
Curry, J. F., & Hersh, J. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg06 · Cited by 3
(2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.index
Chapter 9. Posttraumatic Stress Disorder and Substance Use Disorders
Ford, J. D., & Hawke, J. M. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg09 · Cited by 3
Chapter 14. Pathological Preoccupation With the Internet
Yau, Y. H. C., Derevensky, J. L., & Potenza, M. N. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg14 · Cited by 1
Chapter 13. Youth Gambling Problems
Derevensky, J. L. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg13 · Cited by 3
(2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.fm01
Chapter 8. Anxiety Disorders and Substance Use Disorders
Black, J. J., Chung, T. A., & Clark, D. B. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg08 · Cited by 3
Chapter 3. Screening, Assessment, and Treatment Options for Youths With a Substance Use Disorder
Kaminer, Y., Winters, K. C., & Kelly, J. F. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg03 · Cited by 1
Chapter 7. Bipolar Disorders and Substance Use Disorders
Duffy, A. C., & Nemati, M. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg07
Chapter 10. Suicidal and Nonsuicidal Self-Harm Behaviors and Substance Use Disorders
Esposito-Smythers, C. L., Perloe, A., Machell, K. A., & Rallis, B. A. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg10 · Cited by 2
Fishman, M. J. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg02 · Cited by 2
Chapter 11. Schizophrenia and Substance Use Disorders
Bagot, K. S., & Milin, R. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg11
Chapter 5. Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders
Wilens, T. E., & Zulauf-McCurdy, C. A. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg05 · Cited by 3
Linking Substance Use and Schizophrenia
Mutlu, E., Özden, H. C., & Ertuğrul, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_179
Chapter 4. Conduct Disorder and Delinquency and Substance Use Disorders
Bukstein, O. G. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg04 · Cited by 4
Tarter, R. E., & Horner, M. S. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg01 · Cited by 3
Chapter 12. Eating Disorders and Substance Use Disorders
Baker, J. H., Metzger, L. M., & Bulik, C. M. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg12
Striebel, J. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009587747.004
Odenwald, M. G., Oetzel, L., Atkinson, H. F., Widmann, M., Mekonnen, Z., Soboka, M., Müller-Bamouh, V., Suleman, S., Tessema, F., Toennes, S. W., et al. (2026) · medRxiv · doi:10.64898/2026.09.27.26364112
Seeley, S. L., Snyder, M., & D’Souza, M. S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116530
Metadata
- Authors
- Callaghan, R. C., Cunningham, J. K., Allebeck, P., Arenovich, T., Sajeev, G., Remington, G., Boileau, I., & Kish, S. J.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- From the Centre for Addiction and Mental Health, Toronto; the Dalla Lana School of Public Health, the Departments of Psychiatry and Pharmacology, Faculty of Medicine, and the Institute of Medical Science, University of Toronto, Toronto; the Department of Family and Community Medicine, University of Arizona, Tucson; and the Department of Public Health Sciences, Karolinska Institutet, Stockholm.
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2012-04
- Volume
- 169
- Issue
- 4
- Pages
- 389-396
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2055556070
- Cited by
- 150
- References
- 30
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 13 · 2015: 35 · 2014: 9 · 2013: 13 · 2012: 6
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA025096, DA071301, DA025096)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine use, schizophrenia, drug use disorders, cannabis use disorder, cocaine dependence, opioid use disorder, alcoholism, psychosis, hospital discharge data, propensity score matching, schizophrenia risk
- MeSH terms
- Adult, California, Female, Humans, Male, Methamphetamine, Middle Aged, Risk Factors, Schizophrenia, Schizophrenic Psychology, Cohort Studies, Diagnosis, Dual (Psychiatry), Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.